Literature DB >> 357240

Effect of intravenous infusion of somatostatin on gastric, pancreatic and biliary secretion in the rat.

M Moriga, K Kojima, M Aono, H Uchino, H Yajima.   

Abstract

The effect of somatostatin (GH-RIH) on gastric, pancreatic and biliary secretion was examined in the anesthetized rats. Intravenous infusion of the hormone, in graded doses ranging from 1 to 16 microgram/kg/hr, produced a dose dependent inhibition of pentagastrin, 1.5 microgram/kg/hr, induced acid secretion, reaching about 54% of control level at the dose of 16 microgram/kg/hr. Somatostatin, 4, 16 and 64 microgram/kg/hr, inhibited the pancreatic juice volume stimulated by intravenous injection of secretin, 1 u/kg, as a bolus. Somatostastin, 2, 8, 32 and 128 microgram/kg/30 min, did not change the bile flow rate in control period. Somatostatin may play a physiological role in the regulation of the secretory process of the stomach and pancreas.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 357240     DOI: 10.1007/bf02773663

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  35 in total

1.  The mechanism whereby growth hormone-release inhibiting hormone (somatostatin) inhibits food stimulated gastric acid secretion in the cat.

Authors:  M Albinus; E L Blair; E R Grund; J D Reed; D J Sanders; A Gomez-Pan; A V Schally; G M Besser
Journal:  Agents Actions       Date:  1975-10

2.  Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion.

Authors:  S J Konturek; J Tasler; W Obtulowicz; D H Coy; A V Schally
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

3.  Effect of somatostatin on meal-induced gastric secretion in duodenal ulcer patients.

Authors:  S J Konturek; J Swierczek; N Kwiecień; E Mikoś; J Oleksy; Z Wierzbicki
Journal:  Am J Dig Dis       Date:  1977-11

4.  Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

Authors:  C H Mortimer; W M Tunbridge; D Carr; L Yeomans; T Lind; D H Coy; S R Bloom; A Kastin; C N Mallinson; G M Besser; A V Schally; R Hall
Journal:  Lancet       Date:  1974-04-20       Impact factor: 79.321

5.  Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone.

Authors:  S R Bloom; C H Mortimer; M O Thorner; G M Besser; R Hall; A Gomez-Pan; V M Roy; R C Russell; D H Coy; A J Kastin; A V Schally
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

6.  Inhibition of insulin secretion by somatostatin.

Authors:  K G Alberti; N J Christensen; S E Christensen; A P Hansen; J Iversen; K Lundbaek; K Seyer-Hansen; H Orskov
Journal:  Lancet       Date:  1973-12-08       Impact factor: 79.321

7.  Direct inhibition of gastric acid by growth-hormone release-inhibiting hormone in dogs.

Authors:  A A Barros D'Sa; S R Bloom; J H Baron
Journal:  Lancet       Date:  1975-04-19       Impact factor: 79.321

8.  [Effect of somatostatin on betazole-stimulated gastric secretion and carbachol-stimulated pancreatic secretion and gall bladder contraction in man(author's transl)].

Authors:  P G Lankisch; R Arnold; W Creuzfeldt
Journal:  Dtsch Med Wochenschr       Date:  1975-09-05       Impact factor: 0.628

9.  Anti-stress ulcer and anti-secretory effect of somatostatin in rats -- failure to suppress serum gastrin.

Authors:  P O Schwille; F Putz; R Thun; W Schellerer; G Draxler; G Lang
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1977-08

10.  THE ESTIMATION OF PEPSIN WITH HEMOGLOBIN.

Authors:  M L Anson; A E Mirsky
Journal:  J Gen Physiol       Date:  1932-09-20       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.